Cannabis Report
High Times
Home > Boards > US OTC > Medical - Drugs >

Innovation Pharmaceuticals Inc. (IPIX)

IPIX RSS Feed
Add IPIX Price Alert      Hide Sticky   Hide Intro
Moderator: LilKahuna, tryz, BooDog, sox040713, 123tom, scottsmith
Search This Board: 
Last Post: 9/25/2018 5:31:01 PM - Followers: 754 - Board type: Free - Posts Today: 70

Innovation Pharmaceuticals Inc. (IPIX)

https://www.sec.gov/Archives/edgar/data/1355250/000147793217002710/ctix_8k.htm
 

http://www.ipharminc.com/

 
Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
Email:  info@ipharminc.com

 
About Innovation Pharmaceuticals Inc.: 

Headquartered in Beverly, Massachusetts, Innovation Pharmaceuticals is a publicly-traded company under the symbol "IPIX".
Innovation Pharmaceuticals is a clinical stage biopharmaceutical company developing innovative therapies in multiple diseases. Innovation Pharmaceuticals believes it has a world-class portfolio of first-in-class lead drug candidates and is now advancing them toward market approval, while actively seeking strategic partnerships. Innovation Pharmaceuticals' psoriasis drug candidate Prurisol completed a Phase 2 trial and Innovation Pharmaceuticals is nearing completion of a Phase 2b study. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Innovation Pharmaceuticals' anti-cancer drug Kevetrin successfully concluded a Phase 1 clinical trial at Harvard Cancer Centers' Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center, and Innovation Pharmaceuticals has commenced a Phase 2 study. In the laboratory, Kevetrin has shown to induce activation of p53, often referred to as the "Guardian Angel Gene" due to its crucial role in controlling cell mutations. Innovation Pharmaceuticals is in a Phase 2 clinical trial with its novel compound Brilacidin-OM (a defensin mimetic compound) for the prevention of oral mucositis in patients with head and neck cancer. Interim analysis has shown Brilacidin-OM to have a high potential for prevention of severe oral mucositis. Clinical results are consistent with those seen in an animal model in which the occurrence of severe ulcerative oral mucositis was reduced by more than 94% compared to placebo. Innovation Pharmaceuticals' lead antibiotic, Brilacidin, has completed a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infection, or ABSSSI. Top-line data have shown a single dose of Brilacidin to deliver comparable clinical outcomes to the FDA-approved seven-day dosing regimen of daptomycin. Brilacidin has the potential to be a single-dose therapy for certain multi-drug resistant bacteria ("superbugs"). In an ongoing Phase 2 open label Proof-of-Concept trial, favorable interim results have been observed in the first two cohorts of patients treated with Brilacidin for Ulcerative Proctitis/Ulcerative Proctosigmoiditis (UP/UPS), two types of Inflammatory Bowel Disease (IBD).  Innovation Pharmaceuticals has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna. More information is available at http://www.ipharminc.com.

Management: http://www.cellceutix.com/senior-management/

Ongoing Human Trials:  http://clinicaltrials.gov/ct2/results?term=Cellceutix+Pharmaceuticals&Search=Search
 
Product Pipeline:  http://www.ipharminc.com/therapeutic-areas/

 

PIPELINE: 

FDA DESIGNATIONS:

2017 MILESTONES:



Recent News and Press Releases: 
https://finance.yahoo.com/quote/IPIX?p=IPIX
http://www.ipharminc.com/press-release/

 
SEC Filings (CIK:0001355250): 
https://www.sec.gov/cgi-bin/browse-edgar?company=Innovation+Pharmaceutical&owner=exclude&action=getcompany

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f
cs@wcsti.com
http://www.westcoaststocktransfer.com

 
Share Structure:  See SEC filing link above for current share structure

 

Cellceutix IP - Patent Filings:

EPO
http://worldwide.espacenet.com/searchResults?PA=Cellceutix&DB=EPODOC&locale=en_EP&ST=advanced&compact=false
WIPO
http://www.wipo.int/patentscope/search/en/detail.jsf?docId=WO2010135170&recNum=1&docAn=US2010034838&queryString=FP:(Cellceutix)&maxRec=1
USPTO
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=Cellceutix&FIELD1=AS&co1=AND&TERM2=&FIELD2=&d=PG01 


http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,796,275.PN.&OS=PN/8,796,275&RS=PN/8,796,275
 

Publication number US8338454 B2
Publication type Grant
Application number US 12/780,132
Publication date Dec 25, 2012
Filing date May 14, 2010
Priority date May 20, 2009
Also published as CA2762427A1, CN102438612A, EP2432464A2, US20100298374, US20130245062, WO2010135170A2, WO2010135170A3, Less «6 More »
Publication number 12780132, 780132, US 8338454 B2, US 8338454B2, US-B2-8338454, US8338454 B2, US8338454B2
Inventors Krishna Menon
Original Assignee Cellceutix Corporation
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (6), Non-Patent Citations (41), Referenced by (1), Classifications (42)
 
External Links: USPTO, USPTO Assignment, Espacenet

http://www.google.com/patents/US8338454

http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=6&f=G&l=50&co1=AND&d=PG01&s1=Cellceutix.AS.&OS=AN/Cellceutix&RS=AN/Cellceutix

 
Investor Relations: 

http://www.ipharminc.com/new-faq/
http://www.ipharminc.com/contact-us-1


Following is a DAILY chart:


 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
 
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
 
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

Cannabis Report
High Times
IPIX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
IPIX News: Statement of Changes in Beneficial Ownership (4) 09/24/2018 04:36:47 PM
IPIX News: Statement of Changes in Beneficial Ownership (4) 09/24/2018 04:33:20 PM
IPIX News: Current Report Filing (8-k) 09/21/2018 04:03:40 PM
IPIX News: Annual Report (10-k) 09/11/2018 04:04:21 PM
IPIX News: Current Report Filing (8-k) 06/29/2018 02:11:50 PM
PlusOneCoin Top Posts
#239252   lol. A for the ipix effort. TheHound 09/03/18 10:18:02 AM
#242563   Re today’s early morning (for me) PR – slcimmuno 09/24/18 08:15:41 AM
#242650   Brilacidin for Oral Mucositis: At-a-Glance Comparative Data Presentation georgejjl 09/24/18 07:39:41 PM
PostSubject
#240994  Sticky Note Deal is in the works “The Company signed a Cherry_11 09/14/18 08:44:26 AM
#240968  Sticky Note I was also shocked and it hasn't dissipated. Detonate 09/14/18 05:51:10 AM
#235000  Sticky Note IPIX Milestones, Clinical Trials, Recent Articles, Corporate Overview, Patent sox040713 07/21/18 11:52:18 PM
#242745   "...one does not exercise options unless there is loanranger 09/25/18 05:31:01 PM
#242744   Correct. MrW 09/25/18 05:15:01 PM
#242743   Max Still a good investment into IPIX. ECHO20 Echo20 09/25/18 04:55:03 PM
#242742   https://ih.advfn.com/p.php?pid=nmona&article=78320242 TheDane 09/25/18 04:30:24 PM
#242741   Your wrong oldguy76 09/25/18 04:06:18 PM
#242740   down 8% - I knew this piece of MXAMDUD 09/25/18 03:57:12 PM
#242739   So....AB got 1,066,000 shares for nothing and JH noretreat 09/25/18 03:50:05 PM
#242738   Bipolar much? joseytheoutlawwales 09/25/18 03:27:08 PM
#242737   spot on called it that this POS is MXAMDUD 09/25/18 03:22:36 PM
#242736   where did you see this tia jsc52033 09/25/18 03:20:46 PM
#242735   HQ watch! Amazon and IPIX- To infinity and beyond! 09/25/18 03:15:00 PM
#242734   The company posts pretty careful comparative data for To infinity and beyond! 09/25/18 03:13:59 PM
#242733   another shittttty day - limping into the close MXAMDUD 09/25/18 03:13:47 PM
#242732   seekthelight, You are correct, ¨These options have not even kfcyahoo 09/25/18 03:05:01 PM
#242731   just filled a 4000 buy at the .2825 MXAMDUD 09/25/18 02:57:52 PM
#242730   I also do not believe the shares were biopa 09/25/18 02:46:51 PM
#242729   What in the H--L is wrong with you seek the light 09/25/18 02:46:18 PM
#242728   zandant, Thx, glad you read as intended. What would kfcyahoo 09/25/18 02:36:11 PM
#242727   zandant.....I do not believe they exercised those options. seek the light 09/25/18 02:36:05 PM
#242726   Thanks for mentioning this! Looking great!! JPsooner 09/25/18 02:36:01 PM
#242725   Very Impressive!!!....IPIX Board of Directors in a sec tryz 09/25/18 02:22:55 PM
#242724   I see the exercise price but under amount MXAMDUD 09/25/18 02:17:21 PM
#242723   ...one does not exercise options unless there is Justfactsmam 09/25/18 02:12:31 PM
#242722   Max Notice how CRITICAL MANY ON THIS BOARD ARE NOW. ECHO20 Echo20 09/25/18 02:07:43 PM
#242721   Max. Still buys. Echo20 Echo20 09/25/18 02:06:35 PM
#242720   Haha. OK. That was funny. zandant 09/25/18 01:52:30 PM
#242719   that was the exercise price. BUT they MXAMDUD 09/25/18 01:52:10 PM
#242718   ¨Any thoughts on the options exercised by H kfcyahoo 09/25/18 01:39:09 PM
#242717   I assume you are upside down on this bradfordbros 09/25/18 01:33:08 PM
#242716   Now 131k shares. HOD .3136. I can see TheDane 09/25/18 01:19:24 PM
#242715   How much out of pocket are Art and scottsmith 09/25/18 01:18:31 PM
#242714   Those are the ones. Why do you zandant 09/25/18 01:12:35 PM
#242713   What was positive about it? Make the scottsmith 09/25/18 01:10:52 PM
#242712   Anything positive is a "non event" to you.. lol cybermich 09/25/18 01:07:43 PM
#242711   Do you mean yesterday afternoon filings? Looks scottsmith 09/25/18 12:58:22 PM
#242710   Any thoughts on the options exercised by H zandant 09/25/18 12:55:33 PM
#242709   did they pay anything to exercise at .38? MXAMDUD 09/25/18 12:53:32 PM
#242708   Maxdud Lok in NEWS on Ihub. Hurry. Echo20 09/25/18 12:38:57 PM
#242707   Here is the one for Dr B - zandant 09/25/18 12:25:39 PM
#242706   Lol yea right! scottsmith 09/25/18 12:25:36 PM
#242705   I believe Echo's reference is to the two zandant 09/25/18 12:20:58 PM
#242704   Empiricist1.....You are welcome. But of course i hope seek the light 09/25/18 12:15:03 PM
#242703   Great stuff, seek the light. Many thanks for Empiricst1 09/25/18 12:09:38 PM
#242702   proof???? MXAMDUD 09/25/18 12:00:48 PM
#242701   Leo and Menon should retire 15-30 million shares.. tombrady12nh 09/25/18 11:47:22 AM
#242700   Empiricst1.....I think i found the starting point if seek the light 09/25/18 11:32:16 AM
#242699   I dont post here very often...but have been Lwe6638 09/25/18 11:24:12 AM
#242698   It's on less than 47,000 shares. So far Blues44 09/25/18 11:07:45 AM
#242697   They were given shares and options a month loanranger 09/25/18 11:02:53 AM
#242696   The ASK is holding firm at .31. Hmm. TheDane 09/25/18 10:59:36 AM
PostSubject